Serum levels of Krebs von den Lungen-6 (KL-6) are useful markers for the diagnosis and monitoring of ILD, although they often remain moderately high despite apparent clinical and radiological improvements during CsA treatment [171]. The gene discussed is MUC1; the disease is interstitial lung disease.